In vitro effects of an in silico-modelled 17β-estradiol derivative in combination with dichloroacetic acid on MCF-7 and MCF-12A cells. (Q46449939)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992416%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

In vitro effects of an in silico-modelled 17β-estradiol derivative in combination with dichloroacetic acid on MCF-7 and MCF-12A cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992416%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496326&resulttype=core&format=json

14 May 2020

author name string

X X Stander

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496326&resulttype=core&format=json

14 May 2020

B A Stander

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496326&resulttype=core&format=json

14 May 2020

publication date

13 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992416%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496326&resulttype=core&format=json

14 May 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496326&resulttype=core&format=json

14 May 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496326&resulttype=core&format=json

14 May 2020

page(s)

567-581

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496326&resulttype=core&format=json

Targeting microtubules for cancer chemotherapy

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Microtubulin binding sites as target for developing anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Microtubules as a target for anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Modulation of microtubule dynamics by tau in living cells: implications for development and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

In vitro effects of 2-methoxyestradiol on morphology, cell cycle progression, cell death and gene expression changes in the tumorigenic MCF-7 breast epithelial cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

2-Methoxyestradiol--biology and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

In vitro effects of 2-methoxyestradiol on cell morphology and Cdc2 kinase activity in SNO oesophageal carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

In vitro effects of 2-methoxyestradiol on MCF-12A and MCF-7 cell growth, morphology and mitotic spindle formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

In vitro effects of 2-methoxyestradiol-bis-sulphamate on the non-tumorigenic MCF-12A cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Selective insensitivity of ZR-75-1 human breast cancer cells to 2-methoxyestradiol: evidence for type II 17beta-hydroxysteroid dehydrogenase as the underlying cause

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Docking, synthesis, and in vitro evaluation of antimitotic estrone analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

The in vitro effects of 2-methoxyestradiol-bis-sulphamate on cell numbers, membrane integrity and cell morphology, and the possible induction of apoptosis and autophagy in a non-tumorigenic breast epithelial cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Carbonic anhydrases as targets for medicinal chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Lactic acidosis triggers starvation response with paradoxical induction of TXNIP through MondoA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Oxidative metabolism in cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Dichloroacetate (DCA) enhances tumor cell death in combination with oncolytic adenovirus armed with MDA-7/IL-24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Hypersensitization of tumor cells to glycolytic inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Dynamic monitoring of cytotoxicity on microelectronic sensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Dichloroacetate induces apoptosis in endometrial cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Methods for monitoring autophagy from yeast to human

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Mechanism of 2-methoxyestradiol-induced apoptosis and growth arrest in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Regulation of autophagy by ROS: physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00789.X

Determination of cell number in monolayer cultures

21 January 2018

1 reference

12 December 2020

Energy deregulation: licensing tumors to grow

1 reference

12 December 2020

Influence of 2-methoxyestradiol on MCF-7 cells: an improved differential interference contrasting technique and Bcl-2 and Bax protein expression levels.

1 reference

12 December 2020

Live cell quality control and utility of real-time cell electronic sensing for assay development

1 reference

12 December 2020

Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer

1 reference

12 December 2020

In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol

1 reference

12 December 2020

Quantification of cells cultured on 96-well plates

1 reference

12 December 2020

The National Cancer Institute: cancer drug discovery and development program

1 reference

12 December 2020

In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds

1 reference

12 December 2020

10.1111/J.1365-2184.2011.00789.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496326&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496326&resulttype=core&format=json

14 May 2020

1 reference